Global Health Ltd: Intrinsic Value & Share Price Analysis

Q: What is the current share price and 52-week range of Global Health Ltd?

Global Health Ltd is trading at 989.00 as of 23 April 2026, with a FY2026-2027 high of 1,456 and low of 955. The stock is currently near its 52-week low. Market cap stands at 26,589 Cr..

Q: Is Global Health Ltd financially healthy?

Key indicators: ROCE of 19.7 % indicates efficient capital utilization. Dividend yield is 0.05 %.

Q: Is Global Health Ltd profitable and how is the profit trend?

Global Health Ltd reported a net profit of 481 Cr in Mar 2025 on revenue of 3,692 Cr. Compared to 196 Cr in Mar 2022, the net profit shows an improving trend.

Fair Value

₹856.58Overvalued by 13.39%vs CMP ₹989.00

P/E (47.0) × ROE (16.5%) × BV (₹138.00) × DY (0.05%)

₹412.13Overvalued by 58.33%vs CMP ₹989.00

MoS: -140% (Negative)Confidence: 63/100 (Moderate)Models: 1 Fair, 8 Over

Model	Category	Value	Weight	Signal
PE-ROE	Earnings	₹1,026.24	23%	Fair (+3.8%)
Graham Number	Earnings	₹243.72	17%	Over (-75.4%)
Earnings Power	Earnings	₹105.32	11%	Over (-89.4%)
DCF	Cash Flow	₹430.51	11%	Over (-56.5%)
Net Asset Value	Assets	₹137.92	7%	Over (-86.1%)
EV/EBITDA	Enterprise	₹366.56	9%	Over (-62.9%)
Earnings Yield	Earnings	₹191.30	7%	Over (-80.7%)
ROCE Capital	Returns	₹62.74	7%	Over (-93.7%)
Revenue Multiple	Revenue	₹137.33	6%	Over (-86.1%)
Consensus (9 models)		₹412.13	100%	Overvalued

Key Drivers: Wide model spread (₹63–₹1,026) — high uncertainty.

PE-ROE · Graham · EPV · DCF · NAV · EV/EBITDA · DDM · Earnings Yield · ROCE Capital · Revenue Multiple | CoE: 12% · Terminal: 4% · EPS CAGR: 19.8%

*Investments are subject to market risks

Analyst Summary

Global Health Ltd operates in the Non-Banking Financial Company (NBFC) segment, NSE: MEDANTA | BSE: 543654, current market price is ₹989.00, market cap is 26,589 Cr.. At a glance, stock P/E is 47.0, ROE is 16.5 %, ROCE is 19.7 %, book value is 138, dividend yield is 0.05 %. The latest intrinsic value estimate is ₹412.13, around 58.3% below the current price, so expectations may already be running ahead of this modelled fair value. On operating trend, latest reported sales are about ₹3,692 Cr versus the prior period change of 12.7%, while latest net profit is about ₹481 Cr with a prior-period change of 0.6%. The 52-week range shown on this page is 1,456/955, which helps frame where the current quote sits within its recent trading band. Business context: About the Company - Qualitative AnalysisGlobal Capital Markets Ltd. is a Public Limited Listed company incorporated on 20/02/1989 and has its registered office in the State of West Bengal, India. Company's Corporate Identification Number(CI…

This summary is generated from the stock page data available for Global Health Ltd: Intrinsic Value & Share Price Analysis and is refreshed automatically when the underlying metrics change.

Investment Snapshot

Global Health Ltd scores 64/100 (Average)

Based on 5 dimensions: health, institutional flow, earnings quality, momentum, and peer comparison

Stock Health72/100 · Strong

ROCE 19.7% GoodROE 16.5% GoodD/E 0.47 ModerateInterest Coverage 0.0x RiskyProfitable 5/5 years Consistent

Smart Money45/100 · Moderate

FII holding down -1.22% (6mo) SellingDII holding up 2.06% MF buyingPromoter holding at 33.0% Stable

Earnings Quality50/100 · Moderate

OPM stable around 25% Steady

Quarterly Momentum58/100 · Moderate

Revenue (4Q): +17% YoY GrowingProfit (4Q): +1% YoY PositiveOPM: 19.0% (down 6.0% YoY) Margin pressure

Industry Rank90/100 · Strong

P/E 47.0 vs industry 101.6 Cheaper than peersROCE 19.7% vs industry 15.8% Above peersROE 16.5% vs industry 8.8% Above peers3Y sales CAGR: 19% Moderate

Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily. Not investment advice.

Share Price and Basic Stock Data

Last Updated: April 2, 2026, 4:41 am

Market Cap	26,589 Cr.
Current Price	989
Intrinsic Value	₹412.13
High / Low	1,456/955
Stock P/E	47.0
Book Value	138
Dividend Yield	0.05 %
ROCE	19.7 %
ROE	16.5 %
Face Value	2.00
PEG Ratio	2.37

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Global Health Ltd

Competitors

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
Global Health Ltd	26,589 Cr.	989	1,456/955	47.0	138	0.05 %	19.7 %	16.5 %	2.00
Capri Global Capital Ltd	16,932 Cr.	176	214/151	20.1	69.4	0.11 %	11.2 %	11.8 %	1.00
Authum Investment & Infrastructure Ltd	36,729 Cr.	432	684/271	10.1	192	0.05 %	30.3 %	33.9 %	1.00
Five-Star Business Finance Ltd	10,628 Cr.	360	850/338	9.59	231	0.56 %	16.3 %	18.6 %	1.00
SBFC Finance Ltd	9,291 Cr.	84.0	123/79.6	22.0	31.3	0.00 %	11.6 %	11.6 %	10.0
Industry Average	22,241.21 Cr	369.74		101.56	513.16	0.26%	15.81%	8.84%	8.50

All Competitor Stocks of Global Health Ltd

Quarterly Result

Metric	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Sales	694	707	780	844	836	809	861	957	943	931	1,031	1,099	1,121
Expenses	534	540	595	631	620	629	675	728	706	707	784	868	904
Operating Profit	160	167	184	213	216	179	186	228	238	225	247	231	217
OPM %	23%	24%	24%	25%	26%	22%	22%	24%	25%	24%	24%	21%	19%
Other Income	12	25	15	21	18	27	22	18	16	-27	20	36	-15
Interest	21	20	18	20	18	18	18	16	16	15	14	17	22
Depreciation	39	38	40	43	44	45	47	49	48	49	45	50	61
Profit before tax	112	133	141	171	172	143	144	181	189	133	208	200	120
Tax %	28%	24%	28%	27%	28%	11%	26%	28%	24%	24%	24%	21%	21%
Net Profit	81	101	102	125	124	127	106	131	143	101	159	158	95
EPS in Rs	3.01	3.77	3.80	4.66	4.61	4.74	3.96	4.87	5.32	3.78	5.92	5.89	3.54

Last Updated: March 3, 2026, 9:34 am

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: February 27, 2026, 5:55 am

Metric	Mar 2016	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	TTM
Sales	1,382	1,343	1,456	1,500	1,447	2,167	2,710	3,275	3,692	4,182
Expenses	1,081	1,218	1,283	1,309	1,250	1,709	2,073	2,466	2,806	3,263
Operating Profit	301	125	172	192	197	458	637	809	886	920
OPM %	22%	9%	12%	13%	14%	21%	24%	25%	24%	22%
Other Income	45	49	50	44	31	39	49	75	29	14
Interest	14	28	38	57	73	86	86	84	74	67
Depreciation	70	86	102	115	123	130	150	173	194	205
Profit before tax	262	60	83	64	32	281	449	627	647	661
Tax %	35%	45%	38%	43%	11%	30%	27%	24%	26%
Net Profit	170	33	51	36	29	196	326	478	481	514
EPS in Rs	35.10	6.78	10.44	7.36	5.81	7.75	12.16	17.81	17.92	19.13
Dividend Payout %	0%	0%	0%	0%	0%	0%	0%	0%	0%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024	2024-2025
YoY Net Profit Growth (%)	54.55%	-29.41%	-19.44%	575.86%	66.33%	46.63%	0.63%
Change in YoY Net Profit Growth (%)	0.00%	-83.96%	9.97%	595.31%	-509.54%	-19.70%	-46.00%

Global Health Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 7 years from 2018-2019 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:	%
5 Years:	20%
3 Years:	19%
TTM:	15%

Compounded Profit Growth
10 Years:	%
5 Years:	70%
3 Years:	38%
TTM:	18%

Stock Price CAGR
10 Years:	%
5 Years:	%
3 Years:	%
1 Year:	24%

Return on Equity
10 Years:	%
5 Years:	14%
3 Years:	17%
Last Year:	16%

Last Updated: September 5, 2025, 3:36 pm

Balance Sheet

Last Updated: February 1, 2026, 2:52 am

Month	Mar 2016	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Sep 2025
Equity Capital	48	48	49	49	50	51	54	54	54	54
Reserves	976	1,136	1,246	1,300	1,333	1,565	2,375	2,852	3,333	3,654
Borrowings	165	456	787	929	931	1,109	1,122	802	718	945
Other Liabilities	295	343	347	388	380	421	547	572	662	757
Total Liabilities	1,485	1,984	2,430	2,666	2,694	3,146	4,097	4,280	4,766	5,410
Fixed Assets	914	1,094	1,194	1,703	1,616	1,776	2,050	2,236	2,514	3,199
CWIP	12	317	666	382	464	439	327	388	533	318
Investments	0	0	0	0	0	0	0	0	3	3
Other Assets	559	573	570	581	615	930	1,720	1,656	1,716	1,890
Total Assets	1,485	1,984	2,430	2,666	2,694	3,146	4,097	4,280	4,766	5,410

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2016	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity +	228	63	166	175	242	311	645	612	624
Cash from Investing Activity +	-241	-69	-249	-87	-239	-421	-342	-441	-721
Cash from Financing Activity +	-7	9	97	-1	-81	160	346	-514	-97
Net Cash Flow	-20	3	14	87	-78	50	648	-343	-194
Free Cash Flow	71	-81	-133	-13	100	38	409	335	110
CFO/OP	108%	93%	135%	121%	131%	89%	118%	98%	89%

Free Cash Flow

Month	Mar 2016	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Free Cash Flow	136.00	-331.00	-615.00	-737.00	-734.00	457.00	636.00	7.00	168.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2016	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Debtor Days	20	41	41	36	34	30	26	24	29
Inventory Days	28	26	26	43	42	36	35	32	28
Days Payable	92	124	142	147	138	90	114	90	81
Cash Conversion Cycle	-45	-56	-75	-67	-62	-24	-52	-34	-24
Working Capital Days	-23	-33	-18	-31	-48	-20	-37	-32	-21
ROCE %			6%	6%	5%	15%	17%	20%	20%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Promoters	33.08%	33.07%	33.06%	33.05%	33.04%	33.04%	33.04%	33.03%	33.03%	33.01%	33.01%	33.01%
FIIs	9.89%	10.58%	10.69%	11.36%	12.10%	12.94%	12.21%	12.48%	11.76%	11.54%	11.41%	10.54%
DIIs	12.34%	10.79%	10.93%	11.15%	10.25%	10.57%	11.11%	10.51%	11.93%	12.20%	12.97%	13.99%
Public	44.67%	45.55%	45.31%	44.45%	44.60%	43.44%	43.64%	43.98%	43.28%	43.19%	42.56%	42.41%
Others	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.06%	0.06%	0.06%
No. of Shareholders	1,07,120	1,09,798	1,16,627	1,24,775	1,66,253	1,55,307	1,49,722	1,48,633	1,54,688	1,56,372	1,55,806	1,51,241

Shareholding Pattern Chart

No. of Shareholders

Global Health Ltd: Intrinsic Value & Share Price Analysis - Shareholder trend analysis

This stock is not held by any mutual fund.

ROCE / ROE Trend

EPS Trend

Key Financial Ratios

Month	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
FaceValue	2.00	2.00	2.00	2.00	10.00
Basic EPS (Rs.)	17.92	17.80	12.58	7.78	1.15
Diluted EPS (Rs.)	17.92	17.80	12.57	7.77	1.14
Cash EPS (Rs.)	25.13	24.24	17.75	12.87	30.66
Book Value[Excl.RevalReserv]/Share (Rs.)	126.08	108.21	90.54	63.82	272.22
Book Value[Incl.RevalReserv]/Share (Rs.)	126.08	108.21	90.54	63.82	272.22
Revenue From Operations / Share (Rs.)	137.47	121.98	100.46	85.56	291.76
PBDIT / Share (Rs.)	35.60	32.54	25.25	19.34	44.94
PBIT / Share (Rs.)	28.39	26.11	19.66	14.22	20.09
PBT / Share (Rs.)	24.10	23.36	16.75	11.08	6.55
Net Profit / Share (Rs.)	17.92	17.80	12.16	7.75	5.81
NP After MI And SOA / Share (Rs.)	17.92	17.81	12.16	7.75	5.81
PBDIT Margin (%)	25.89	26.67	25.13	22.60	15.40
PBIT Margin (%)	20.64	21.40	19.56	16.61	6.88
PBT Margin (%)	17.52	19.14	16.67	12.94	2.24
Net Profit Margin (%)	13.03	14.59	12.10	9.05	1.99
NP After MI And SOA Margin (%)	13.03	14.60	12.10	9.05	1.99
Return on Networth / Equity (%)	14.21	16.45	13.42	12.14	2.13
Return on Capital Employeed (%)	18.38	19.01	14.87	13.20	4.35
Return On Assets (%)	10.10	11.11	7.92	6.23	1.06
Long Term Debt / Equity (X)	0.07	0.09	0.30	0.47	0.42
Total Debt / Equity (X)	0.09	0.14	0.34	0.51	0.47
Asset Turnover Ratio (%)	0.81	0.77	0.61	0.69	0.52
Current Ratio (X)	2.48	2.44	2.76	1.94	1.24
Quick Ratio (X)	2.37	2.33	2.65	1.81	1.14
Inventory Turnover Ratio (X)	55.11	10.81	9.00	10.58	8.41
Interest Coverage Ratio (X)	14.65	11.82	8.69	6.16	3.32
Interest Coverage Ratio (Post Tax) (X)	9.14	7.47	5.18	3.47	1.43
Enterprise Value (Cr.)	31388.50	34786.03	13675.20	0.00	0.00
EV / Net Operating Revenue (X)	8.50	10.62	5.08	0.00	0.00
EV / EBITDA (X)	32.83	39.81	20.20	0.00	0.00
MarketCap / Net Operating Revenue (X)	8.72	10.85	5.24	0.00	0.00
Price / BV (X)	9.50	12.23	5.81	0.00	0.00
Price / Net Operating Revenue (X)	8.72	10.85	5.24	0.00	0.00
EarningsYield	0.01	0.01	0.02	0.00	0.00

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

About the Company - Qualitative Analysis

Global Capital Markets Ltd. is a Public Limited Listed company incorporated on 20/02/1989 and has its registered office in the State of West Bengal, India. Company's Corporate Identification Number(CIN) is L51109WB1989PLC046292 and registration number is 046292. Currently Company is involved in the business activities of Administration of financial markets. Company's Total Operating Revenue is Rs. 3.29 Cr. and Equity Capital is Rs. 39.83 Cr. for the Year ended 31/03/2025.

INDUSTRY	ADDRESS	CONTACT
Non-Banking Financial Company (NBFC)	Sir RNM House, Kolkata West Bengal 700001	Contact not found

Management
Name	Position Held
Mr. Inder Chand Baid	Chairman & Managing Director
Mr. Mahavir Prasad Saraswat	Independent Director
Mr. Urmi Bose	Independent Director
Ms. Akshaya Suved Chavan	Independent Director
Mr. Manish Baid	Non Executive Director

FAQ

What is the intrinsic value of Global Health Ltd and is it undervalued?

As of 23 April 2026, Global Health Ltd's intrinsic value is ₹412.13, which is 58.33% lower than the current market price of ₹989.00, suggesting the stock is overvalued. This is calculated using the PE ratio method factoring in ROE (16.5 %), book value (₹138), dividend yield (0.05 %), and 5-year EPS CAGR.

What is the current share price and 52-week range of Global Health Ltd?

Global Health Ltd is trading at ₹989.00 as of 23 April 2026, with a FY2026-2027 high of ₹1,456 and low of ₹955. The stock is currently near its 52-week low. Market cap stands at ₹26,589 Cr..

How does Global Health Ltd's P/E ratio compare to its industry?

Global Health Ltd has a P/E ratio of 47.0, which is below the industry average of 101.56. Trading at a steep discount to peers could signal a value opportunity or reflect concerns about the company's fundamentals.

Is Global Health Ltd financially healthy?

Key indicators for Global Health Ltd: ROCE of 19.7 % indicates efficient capital utilization; ROE of 16.5 % shows strong shareholder returns. Dividend yield is 0.05 %.

Is Global Health Ltd profitable and how is the profit trend?

Global Health Ltd reported a net profit of ₹481 Cr in Mar 2025 on revenue of ₹3,692 Cr. Compared to ₹196 Cr in Mar 2022, the net profit shows an improving trend.

Does Global Health Ltd pay dividends?

Global Health Ltd has a dividend yield of 0.05 % at the current price of ₹989.00. The company pays dividends, though the yield is modest.